Persistent Asset Partners »

Atyr Pharma shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Atyr Pharma (ATYR) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Atyr Pharma

Tip: Access up to 7 years of quarterly data

All positions including Atyr Pharma held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atyr Pharma by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $239 55 4.36

More positions owned by Persistent Asset Partners

Viking Therapeutics Call Option (VKTX)
Kodiak Sciences Call Option (KOD)
Corning Incorporated Call Option (GLW)
Eyepoint Com New Call Option (EYPT)
Corbus Pharmaceuticals Hldgs Com New Call Option (CRBP)
Capricor Therapeutics Com New Call Option (CAPR)
United Therapeutics Corporation Call Option (UTHR)
Lumentum Hldgs (LITE)
Sandisk Corp Put Option (SNDK)
Voyager Therapeutics Call Option (VYGR)
Axt (AXTI)
Vaxcyte Call Option (PCVX)
Intel Corporation (INTC)
Tower Semiconductor Shs New (TSEM)
Edgewise Therapeutics Call Option (EWTX)

View all positions for Persistent Asset Partners

Top funds holding Atyr Pharma

FMR
Federated Investors
BlackRock
Vanguard Group
UBS Group
Vanguard Capital Management
Geode Capital Management
State Street Corporation
GSA Capital Partners
Millennium Management
Morgan Stanley
Two Sigma Investments
Susquehanna International
Rosalind Advisors
Northern Trust

View all funds holding Atyr Pharma